22 related articles for article (PubMed ID: 19596910)
1. HER-2 peptides p776 and F7, N-terminal-linked with Ii-Key tetramer (LRMK) help the proliferation of E75-TCR+ cells: The dependency of help on the side chains of LRMK-extended peptide pointed towards the T cell receptor.
Li Y; Ishiyama S; Matsueda S; Tsuda N; Ioannides CG
Oncol Rep; 2008 Jun; 19(6):1445-52. PubMed ID: 18497949
[TBL] [Abstract][Full Text] [Related]
2. Distinct patient responses to activation of T-cells by free HER-2, G89 (777-789) and protected LRMK-linked HER-2, {AE-39 [p776 (Ava-774-788)], AE-47 [(Ava-776-788)] and AE-37[p776 (774-788)]} peptides could lead to development of personalized cancer vaccines.
Li Y; Matsueda S; Efferson CL; Tsuda N; Kawano K; Gao H; Peoples GE; Ioannides CG
Anticancer Res; 2009 Jan; 29(1):41-58. PubMed ID: 19331132
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of undifferentiated, high-TCR density CD8+ cells to methylene groups appended to tumor antigen determines their differentiation or death.
Kawano K; Efferson CL; Peoples GE; Carter D; Tsuda N; Murray JL; Ioannides CG
Cancer Res; 2005 Apr; 65(7):2930-7. PubMed ID: 15805296
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes.
Ko BK; Efferson CL; Kawano K; Kuerer HM; Sahin A; Murray JL; Ioannides CG
Int J Oncol; 2004 Jun; 24(6):1413-8. PubMed ID: 15138582
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15.
Efferson CL; Kawano K; Tsuda N; Palese P; GarcĂa-Sastre A; Ioannides CG
Anticancer Res; 2005; 25(2A):715-24. PubMed ID: 15868901
[TBL] [Abstract][Full Text] [Related]
6. Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation.
Verdeil G; Chaix J; Schmitt-Verhulst AM; Auphan-Anezin N
Eur J Immunol; 2006 Dec; 36(12):3090-100. PubMed ID: 17111352
[TBL] [Abstract][Full Text] [Related]
7. Pathways of memory CD8+ T-cell development.
Bannard O; Kraman M; Fearon D
Eur J Immunol; 2009 Aug; 39(8):2083-7. PubMed ID: 19637204
[TBL] [Abstract][Full Text] [Related]
8. MHC restriction and allogeneic immune responses.
Kazansky DB
J Immunotoxicol; 2008 Oct; 5(4):369-84. PubMed ID: 19404871
[TBL] [Abstract][Full Text] [Related]
9. N-terminally LRMK-linked HER-2 peptides, AE-37 [p776(774-788)] and AE-47 [Ava-F7(776-788)], aid differentiation of E75-TCR+CD8+ cells to perforin-positive cells.
Matsueda S; Gao H; Efferson CL; Tsuda N; Ishiyama S; Li Y; Ioannides MG; Fisk B; Peoples GE; Ioannides CG
Anticancer Res; 2009 Jul; 29(7):2427-35. PubMed ID: 19596910
[TBL] [Abstract][Full Text] [Related]
10. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.
Ramanathan S; Gagnon J; Ilangumaran S
Arch Immunol Ther Exp (Warsz); 2008; 56(5):311-23. PubMed ID: 18836862
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]